Bayer AG has opened the doors at a new multi-million dollar cell therapy production plant in the US to help overcome the manufacturing challenges that companies in the space have struggled to surmount.
Bayer Bids To Become Cell Therapy Manufacturing Leader
The German group has invested $250m into a facility at its campus in Berkeley, CA to produce cell therapies from its own portfolio and for other companies in the space who are looking to tackle the perennial issue of manufacturing.
